Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • Most common adverse events with sofosbuvir/velpatasvir/voxilaprevir are headache, fatigue, diarrhea, and nausea[FDA Sofosbuvir Velpatasvir Voxilaprevir]
  • Few serious adverse events and discontinuations related to treatment occurred in phase III clinical trials[Bourlière 2017]

Action required